Clinical Trial Update: Pilot Study to Establish Safety & Efficacy of a Combination of Dexamethasone and Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukaemia (CLL) [Phase 2]

View source ↗

Summary

A Phase 2 pilot study assessed the safety and efficacy of combining dexamethasone with lenalidomide in patients with relapsed or refractory chronic lymphocytic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: University College, London | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED